Status:
COMPLETED
Exploratory Study of the Relationships Between the Biomarkers of Inflammation, Lipidome and Insulin Resistance and Disorders of Glycemic Regulation in a Cohort of Insulin-resistant Subjects Due to Excess Weight or Dunnigan's Lipodystrophy
Lead Sponsor:
Centre Hospitalier Universitaire de la Réunion
Conditions:
Lipodystrophy
Dunnigan Syndrome
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The objective of this work is to identify biomarkers of interest in patients with insulin resistance leading to early disorders of glycemic regulation. For this the investigators want to assay the ins...
Eligibility Criteria
Inclusion
- Subjects with Dunnigan's Lipodystrophy OR Non-lipodystrophic insulin-resistant subjects OR Insulin-sensitive non-lipodystrophic subjects
- major
- Subjects benefiting from metabolic exploration in the Endocrinology, Diabetology and Nutrition department of the Reunion University Hospital.
- Subject benefiting from an oral glucose tolerance test (OGTT) during his follow-up in the Endocrinology, Diabetology and Nutrition department of the Reunion University Hospital.
- Person affiliated or beneficiary of a social security scheme.
- Subject having been informed of the study in progress and having given their written consent.
Exclusion
- Pregnant woman
- Person under guardianship or curators or deprived of liberty
Key Trial Info
Start Date :
August 17 2021
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
August 16 2023
Estimated Enrollment :
150 Patients enrolled
Trial Details
Trial ID
NCT05424913
Start Date
August 17 2021
End Date
August 16 2023
Last Update
October 25 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
CHU de la Réunion
Saint-Pierre, Reunion, 97448